SeqPlus is an optimized FFPE extraction method developed by Genuity Science which enables higher-quality DNA extraction than conventional methods. Preparing samples for the TSO 500 Assay using SeqPlus ensures that high-quality DNA is used for library preparation meaning more samples pass QC. Learn more by downloading the whitepaper.
Compared to conventional extraction methods, SeqPlus offers:
The TruSightTM Oncology 500 (TSO 500) Assay from Illumina is a comprehensive next-generation sequencing assay that identifies known and emerging biomarkers from tumor samples. Genuity Science offers the complete TSO 500 workflow so you can go from formalin-fixed paraffin-embedded tissue to analyzed data easily. Download the datasheet for more information.
Benefits of the TSO 500 Assay:
The TSO500 Assay is an excellent alternative to whole exome sequencing for panel-based Tumor Mutational Burden analysis.
Global availability means fewer concerns about the accessibility of lab-developed tests at all of your research sites.
Available as a Research Use Only (RUO) assay.